Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Equity-to-Asset : 0.04 (As of Mar. 2008)

Nouveau Life Pharmaceuticals Equity-to-Asset Chart

Nouveau Life Pharmaceuticals Quarterly Data
	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08
Equity-to-Asset	Get a 7-Day Free Trial															0.30	0.24	0.17	0.11	0.04

Competitive Comparison of Nouveau Life Pharmaceuticals's Equity-to-Asset

For the Health Information Services subindustry, Nouveau Life Pharmaceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nouveau Life Pharmaceuticals's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nouveau Life Pharmaceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Nouveau Life Pharmaceuticals's Equity-to-Asset falls into.

Nouveau Life Pharmaceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Nouveau Life Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in Jun. 2006 is calculated as

Nouveau Life Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Mar. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nouveau Life Pharmaceuticals  (OTCPK:NOUV) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Nouveau Life Pharmaceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Nouveau Life Pharmaceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Business Description